-
Clinician-Reported Outcomes—A Rare Opportunity for Orphan Labels?
Mar 10, 2025, 14:00 PM -
Comparing Ex-Vivo and In-Vivo Administration in CRISPR-Based Gene Therapies for Beta-Thalassemia: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients with Sjögren's Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
Economic Analysis of an Optical Neonatal Skin Maturity Meter (MOMPN) in Brazilian Newborns
Mar 10, 2025, 14:00 PM -
What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?
Mar 10, 2025, 14:00 PM -
Virtual Cancer Screening and Support Program: A Model for Improving Cancer Care Continuity Through Screening, Diagnosis, Treatment, and Survivorship
Mar 10, 2025, 14:00 PM -
Is the Biologics Price Competition and Innovation Act Working as Intended?
Mar 10, 2025, 14:00 PM -
The Institute for Clinical and Economic Review’s Incorrect Use of Incremental Cost-Effectiveness Ratios
Mar 10, 2025, 14:00 PM -
TransportHealth: A Novel, Flexible, Open-Source R Package for Transportability and Generalizability Analysis
Mar 10, 2025, 14:00 PM -
Machine Learning Prediction of 3-Year Mortality in Patients Undergoing Percutaneous Coronary Intervention for Coronary Artery Disease
Mar 10, 2025, 14:00 PM -
Benchmarking Duration of Injectable Medication Use: How do Claim Intervals Compare with Days Supply in the Real World?
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Survival Outcomes of Advanced Non-Small Cell Lung Cancer Medicare Patients
Mar 10, 2025, 14:00 PM -
Operational Definitions in Practice: Finding and Evaluating Algorithms for Identifying Patients with Cervical and Uterine Cancer for Real World Data Studies
Mar 10, 2025, 14:00 PM -
Patient and Physician Perspectives on Attributes of IO-Containing Perioperative Treatments in Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer (NSCLC)
Mar 10, 2025, 14:00 PM -
Evaluating the Economic and Environmental Impact of Reprocessed IPC Sleeves for VTE Prophylaxis: a Cost-Consequence Analysis
Mar 10, 2025, 14:00 PM -
Utilizing NLP to Enhance EHR Data Abstraction Accuracy in Waldenström Macroglobulinemia
Mar 10, 2025, 14:00 PM -
Enhancing Health Technology Assessment With Data Transportability Analyses: Addressing Bias and Generalizability Challenges In Non-Local Real-World Evidence
Mar 10, 2025, 14:00 PM -
Continuous Avoidance Cost in Biosimilar: A Budget Impact Analysis on the Basis of Clinical Trial Model and RWD in Brazil / LATAM / LMIC .
Mar 10, 2025, 14:00 PM
